Navigation Links
Kensey Nash Announces $30 Million Share Buyback
Date:2/9/2010

EXTON, Pa., Feb. 9 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that its board of directors has approved a new stock repurchase program.  The new program allows the Company to repurchase an additional $30 million of its issued and outstanding shares of Common Stock, in addition to approximately $3 million currently remaining under the previously announced repurchase program, and has no scheduled expiration.  The Company intends to finance the repurchases using its available cash and liquid investments.

Kensey Nash Corporation plans to repurchase its shares for cash, from time to time in the open market, through block trades or otherwise.  The repurchase program does not require the Company to purchase any specific dollar value or number of shares.  Any purchases under the program will depend on market conditions and may be commenced or suspended at any time or from time to time without prior notice.  As of January 31, 2010, the Company had approximately 10,935,576 shares of Common Stock outstanding.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets.

Cautionary Note for Forward
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
2. Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
3. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
4. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
5. Kensey Nash Announces IDE Submission for Cartilage Repair Device
6. Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators
7. ISTA Pharmaceuticals Announces 2010 Financial Guidance
8. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
9. Hoya Announces Third Quarter Financial Results
10. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
11. PreXion, Inc. Announces Appointment of Director of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: ... pharmaceutical company with the largest cardio-cerebral vascular ("CCV") ... prescription drug market, today announced the unaudited consolidated ... the "Group") for the six months ended 30 ... the Six months ended 30 JuneKey Income Statement ...
(Date:8/27/2014)... N.C. , Aug. 27, 2014 Kewaunee ... its Board of Directors increased its quarterly cash dividend ... eleven cents per outstanding share, beginning with the dividend ... at the close of business on September 8, 2014. ... Founded in 1906, Kewaunee Scientific Corporation is a ...
(Date:8/27/2014)... THOUSAND OAKS, Calif. , Aug. 27, 2014 /PRNewswire/ ... the U.S. Food and Drug Administration (FDA) has granted ... chronic heart failure (HF). Ivabradine is an oral drug ... ("funny" current) in the sinoatrial node, the body,s cardiac ... rate without negative effects on myocardial contractility or ventricular ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 20, 2011 Chembio Diagnostics, Inc. (OTC/QB: CEMI & ... diagnostic tests, announced today that the Company will release ... the open of the market on Thursday, November 3, ... be available immediately after 9:15 a.m. on our web ...
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it ... 30, 2011, on Thursday, October 27, 2011, after the markets close. ... Time to discuss the financial results and provide an update on ... To access the live conference call on October 27, ...
Cached Medicine Technology:Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 2Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 3Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011 2
(Date:8/27/2014)... Germantown, Md., and Denver (PRWEB) August 27, 2014 ... estate developer , has broken ground on a 79,491 ... Holy Cross Health hospital campus in Germantown, an unincorporated ... Germantown is the third most populous place in Maryland, ... on the Holy Cross Germantown Hospital campus is one ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Georgia ... has received a two-year, $600,000 grant from the ... Resources and Services Administration to support implementation of ... services for children and youth with autism spectrum ... worked with an Autism Advisory Council composed of ...
(Date:8/27/2014)... Dr. Winifred S. Hayes, President and CEO ... better health outcomes through the use of evidence, is ... to the executive team effective August 25, 2014. As ... responsible for providing innovation, leadership, and direction in the ... all markets. , “Maura is a highly respected ...
(Date:8/27/2014)... OH (PRWEB) August 27, 2014 ... it simply makes sense to use hearing protection ... hearing forever. There are many different forms of ... use. Employers generally provide hearing protection training and ... and other noisy industries. The National Institute of ...
(Date:8/27/2014)... Orange, NJ. August 27, 2014. Kessler Foundation scientists ... competence in brain injury research and rehabilitation. The ... PhD: Issues of cultural diversity in acquired brain ... Neurorehabilitation . Drs. Lequerica and Krch ... Research at Kessler Foundation and co-investigators for the ...
Breaking Medicine News(10 mins):Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4Health News:Center for Leadership in Disability Awarded $600,000 Grant to Improve Services for Georgia’s Children and Youth with Autism 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 2Health News:Hearing Health Solutions Now Offering a Full Line of Occupation Hearing Protection Services and Expanded Line of Ear Protection Products 3
... conducted among about 200 people with multiple sclerosis ( ... such as pain, tiredness,// emotional well-being, vitality, social functioning, ... living. Results from the MS patients were then compared ... the general population. ,Multiple sclerosis patients in the ...
... help doctors identify which postmenopausal women are at an ... most important// predictor of bone fracture in postmenopausal women ... mineral density is measured by a T-score. As the ... has been what level of a T-score indicates an ...
... standards for measuring blood pressure in children based on age, ... children as young as age 3 should receive regular blood ... percentile for blood pressure are diagnosed with high blood pressure. ... are said to have pre-hypertension -- a relatively new classification ...
... population carries a gene that puts them at risk for ... offspring.// Researchers say they already know one form of the ... to neural tube defects. They speculated another form of the ... ,Researchers studied about 400 people with neural tube defects, comparing ...
... 1 million cases of skin cancer are diagnosed. More than ... more than 7,000 people die yearly. Now, doctors are using ... some patients. ,Mary Louise Gramkow spent her life in ... sort of thing. [I am] just an outdoor person.” All ...
... worn by medical staff carry disease-causing bacteria. Researchers sampled ... and security personnel at a teaching hospital. Their data ... by the medical staff were contaminated with bacteria. ... transfer disease to patients, it is a good opportunity ...
Cached Medicine News:
... Littmann Electronic Stethoscope Model 4100WS features amplification ... allowing you to reduce ambient noise by ... critical body sounds. Three frequency modes are ... other body sounds: Bell (20-200 Hz), Diaphragm ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
... is a portable, battery-powered bone growth stimulator used ... device is worn for 30 minutes each day ... fusion site. The device uses a unique technology, ... energy signal that is very potent in its ...
... is a multi-site, implantable biventricular ... and two ventricular ports for ... (AF) who have undergone an ... have NYHA Class II or ...
Medicine Products: